Chemed (CHE) Other Non-Current Liabilities (2009 - 2026)

Chemed's Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $13.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 3.61% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $13.5 million (up 3.61% YoY), while the FY2025 annual figure was $13.3 million, changed 0.25% from the prior year.
• Other Non-Current Liabilities was $13.5 million for Q1 2026 at Chemed, up from $13.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $13.5 million in Q1 2026 to a low of $10.3 million in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $12.7 million across 5 years, with a median of $13.0 million in 2024.
• Biggest YoY gain for Other Non-Current Liabilities was 25.87% in 2022; the steepest drop was 61.35% in 2022.
• A 5-year view of Other Non-Current Liabilities shows it stood at $12.1 million in 2022, then increased by 7.14% to $13.0 million in 2023, then rose by 2.81% to $13.4 million in 2024, then dropped by 0.25% to $13.3 million in 2025, then gained by 1.41% to $13.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $13.5 million (Q1 2026), $13.3 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.